Understanding Arterial Thrombo Embolic Diseases: Causes, Symptoms, and Treatment
Description
Arterial thrombosis embolic diseases encompass a spectrum of conditions manifested by the formation of blood clots within arteries, resulting. The obstruction of blood flow causes for arterial thrombo embolism diseases include atherosclerosis, hypertension, hyper lipidemia, smoking, diabetes and obesity. Symptoms include chest pain, numbness, weakness of face, arm or leg and shortness of breath. Treatment is based on anti platelet medications, anti coagulant, thrombosis lytic therapy and per cutaneous interventions. Finally it is concluded that by implementing these preventive strategies and effectively managing underlying risk factors, individuals can reduce their likelihood or developing arterial thrombosis embolism diseases and enhance their overall cardio vascular health.
Files
Understanding Arterial Thrombo Embolic Diseases -Formatted Paper.pdf
Files
(281.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:76b3d7e7122606e55ba329e5dfef4bf2
|
281.9 kB | Preview Download |
Additional details
References
- 1. Mackman, N. (2008). Triggers, targets and treatments for thrombosis. Nature, 451(7181), 914-918.
- 2. Prandoni, P. (2017). Venous and arterial thrombosis: is there a link?. Thrombosis and Embolism: from Research to Clinical Practice: Volume 1, 273-283.
- 3. Lowe, G. D. (2004). Venous and arterial thrombosis: epidemiology and risk factors at various ages. Maturitas, 47(4), 259-263.
- 4. Favaloro, E. J., Franchini, M., & Lippi, G. (2014, September). Aging hemostasis: changes to laboratory markers of hemostasis as we age—a narrative review. In Seminars in thrombosis and hemostasis (Vol. 40, No. 06, pp. 621-633). Thieme Medical Publishers.
- 5. Favaloro, E. J., Franchini, M., & Lippi, G. (2014, September). Aging hemostasis: changes to laboratory markers of hemostasis as we age—a narrative review. In Seminars in thrombosis and hemostasis (Vol. 40, No. 06, pp. 621-633). Thieme Medical Publishers.
- 6. Heit, J. A., Spencer, F. A., & White, R. H. (2016). The epidemiology of venous thromboembolism. Journal of thrombosis and thrombolysis, 41, 3-14.
- 7. Liao, S., Woulfe, T., Hyder, S., Merriman, E., Simpson, D., & Chunilal, S. (2014). Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study. Journal of Thrombosis and Haemostasis, 12(2), 214-219.
- 8. Lee, C. H., Lin, L. J., Cheng, C. L., YANG, Y. H. K., Chen, J. Y., & Tsai, L. M. (2010). Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. Journal of Thrombosis and Haemostasis, 8(7), 1515-1523.
- 9. Mosevoll, K. A., Johansen, S., Wendelbo, Ø., Nepstad, I., Bruserud, Ø., & Reikvam, H. (2018). Cytokines, adhesion molecules, and matrix metalloproteases as predisposing, diagnostic, and prognostic factors in venous thrombosis. Frontiers in medicine, 5, 147.
- 10. Insull Jr, W. (2009). The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. The American journal of medicine, 122(1), S3-S14.